Γ

SynBioBeta Speaker

Robert Roscow

Orevo

CEO

Robert Roscow is the CEO and co-founder of Orevo, a company developing the production of SAF and renewable diesel from municipal sewage sludge. He is the inventor of a unique and patent-pending cell free enzymatic process to produce these fuels. Prior to Orevo he has invented and directed patent portfolios across multiple companies including agricultural genome editing and novel pharmaceuticals. Over the course of his career he has led R&D teams, secured IP across biotech and plant genetics, and contributed to over $450M in successful exits.

Sessions Featuring

Robert

This Year

Breakout Session

3:30 PM

-

4:15 PM

Planetary Health

The Feedstock Revolution: Powering the Future of Biomanufacturing

The next leap in biomanufacturing won’t come from better organisms alone; it will come from better inputs. In this session, Erg Bio explores how rethinking feedstocks is unlocking new pathways to scalable, cost-effective, and sustainable production. Feedstocks that could transcend supply chain issues, those that could enable production at any location and on demand! From alternative carbon sources to waste-derived inputs, advances in feedstock innovation will reshape the emerging trillion-dollar bioeconomy. By aligning biology with abundant, low-cost raw materials, the industry can move beyond traditional constraints and build more resilient supply chains, powering a new generation of biomanufacturing at a global scale.

Breakout Session

3:30 PM

-

4:15 PM

Planetary Health

The Feedstock Revolution: Powering the Future of Biomanufacturing

The next leap in biomanufacturing won’t come from better organisms alone; it will come from better inputs. In this session, Erg Bio explores how rethinking feedstocks is unlocking new pathways to scalable, cost-effective, and sustainable production. Feedstocks that could transcend supply chain issues, those that could enable production at any location and on demand! From alternative carbon sources to waste-derived inputs, advances in feedstock innovation will reshape the emerging trillion-dollar bioeconomy. By aligning biology with abundant, low-cost raw materials, the industry can move beyond traditional constraints and build more resilient supply chains, powering a new generation of biomanufacturing at a global scale.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include